Search results
Moderna Shares Had a Bad Day
Barrons.com· 1 day agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment, a new respiratory vaccine, and a possible avian flu...
What's Going On With Moderna Stock Today? - Moderna (NASDAQ:MRNA)
Benzinga· 1 day agoModerna Inc. MRNA shares are trading lower Tuesday. The stock may be pulling back after gaining on bird flu concerns last week and predictions for a slight rise in COVID-19 ...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Cathie Wood's ARK buys AMD, sells Moderna in latest stock trades By Investing.com
Investing.com· 1 day agoCathie Wood's ARK buys AMD, sells Moderna in latest stock trades
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 2 days agoModerna Inc (MRNA, Financial) recently experienced a significant daily loss of 7.74%, yet it boasts a 3-month gain of 72.72%. This analysis aims to explore Moderna ...
...Invest Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4M - ARK Genomic...
Benzinga· 1 day agoThese trades reflect Ark’s strategic adjustments amidst market movements. The AMD Trade Ark bought...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 6 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 4 days agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
Should You Buy This Stock After a Regulatory Setback? | The Motley Fool
The Motley Fool· 4 days agoThe past two-and-a-half years have been rough for Moderna (MRNA 1.58%). The company is developing...
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 6 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
